Access to anti-retroviral drugs, female in Dominican Republic

Dominican Republic: Access to anti-retroviral drugs, female was 68.0% in 2024. ◆ Volatile

Latest (2024)
68.0%
Change on year
up 6.2%
World rank
86th
of 141 countries
All-time high
68.0%
in 2024
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, female in Dominican Republic, 2000–2024

02040602000201220242000: 0 %2001: 0 %2002: 0 %2003: 0 %2004: 1 %2005: 3 %2006: 6 %2007: 10 %2008: 14 %2009: 17 %2010: 22 %2011: 25 %2012: 29 %2013: 30 %2014: 34 %2015: 37 %2016: 39 %2017: 42 %2018: 45 %2019: 47 %2020: 51 %2021: 56 %2022: 63 %2023: 64 %2024: 68 %

Source: UNAIDS estimates. Measured in %.

Analysis

The most recent figure for access to anti-retroviral drugs, female in Dominican Republic is 68.0%, measured in 2024. That is the highest value across all 25 years on record.

That represents a change of up 6.2% on the previous year and up 100.0% over ten years.

Over the whole period, access to anti-retroviral drugs, female in Dominican Republic peaked at 68.0% in 2024 and was at its lowest, 0.0%, in 2000.

Dominican Republic ranks 86th of 141 countries on this measure, in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Access to anti-retroviral drugs, female in Dominican Republic, year by year

Annual values for Access to anti-retroviral drugs, female (%) in Dominican Republic, 2000 to 2024.
Year % Change
2000 0.0%
2001 0.0%
2002 0.0%
2003 0.0%
2004 1.0%
2005 3.0% +200.0%
2006 6.0% +100.0%
2007 10.0% +66.7%
2008 14.0% +40.0%
2009 17.0% +21.4%
2010 22.0% +29.4%
2011 25.0% +13.6%
2012 29.0% +16.0%
2013 30.0% +3.4%
2014 34.0% +13.3%
2015 37.0% +8.8%
2016 39.0% +5.4%
2017 42.0% +7.7%
2018 45.0% +7.1%
2019 47.0% +4.4%
2020 51.0% +8.5%
2021 56.0% +9.8%
2022 63.0% +12.5%
2023 64.0% +1.6%
2024 68.0% +6.2%

Dominican Republic compared with similar countries

  • Dominican Republic's 68.0% is above the median for upper middle income countries, which is 65.0%, 1.0× the median. (39 countries reporting)
  • Dominican Republic's 68.0% is above the median for Latin America & Caribbean, which is 68.0%, 1.0× the median. (23 countries reporting)

Biggest year-on-year movements

Years where Access to anti-retroviral drugs, female in Dominican Republic changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2005 +200.0% 1.0% 3.0%
2006 +100.0% 3.0% 6.0%
2007 +66.7% 6.0% 10.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 5.1% 0.0% 17.0% 10
2010s 35.0% 22.0% 47.0% 10
2020s 60.4% 51.0% 68.0% 5

Countries ranked near Dominican Republic

  1. 84 Lebanon 69.0% compare
  2. 84 Serbia 69.0% compare
  3. 86 Mauritania 68.0% compare
  4. 88 Barbados 67.0% compare
  5. 88 Iraq 67.0% compare
  6. 88 Jordan 67.0% compare

See the full ranking of 160 places →

More gender data for Dominican Republic

All data for Dominican Republic →

Frequently asked questions

What is access to anti-retroviral drugs, female in Dominican Republic?
Access to anti-retroviral drugs, female in Dominican Republic was 68.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, female recorded in Dominican Republic?
The highest recorded value was 68.0% in 2024.
What is the lowest access to anti-retroviral drugs, female recorded in Dominican Republic?
The lowest recorded value was 0.0% in 2000.
How does Dominican Republic rank for access to anti-retroviral drugs, female?
Dominican Republic ranks 86th out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, female rising or falling in Dominican Republic?
Over the last ten years it is up 100.0%. The long-run trend across the full record is volatile.
Where does this Dominican Republic data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, female in Dominican Republic. Statizoid, drawing on UNAIDS estimates. Retrieved 14 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-female-percent/dominican-republic/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-female-percent/dominican-republic/">Access to anti-retroviral drugs, female in Dominican Republic</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, female (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,925 data points, 2000–2024
Last refreshed

The percentage of adult females living with HIV who are receiving antiretroviral therapy.